Table 1: Training and validation data sets used in paclitaxel neoadjuvant therapy sensitivity prediction experiment in breast cancer patients.

From: In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development

End pointTraining setValidation set
GEO data setsNumber of samplesGEO data setsNumber of samples
ERN HER2PGSE20194, GSE2027138GSE32636, GSE5094857
ERN HER2NGSE20194, GSE20271108GSE32646, GSE41998, GSE50948115
All cancer typesGSE20194, GSE20271285GSE22513, GSE32646, GSE41998, GSE50948299